Christopher M Kramer, MD

George A. Beller MD/Lantheus Medical Imaging Distinguished Professor of Cardiovascular Medicine
Chief, Cardiovascular Division

See more at:

Cardiovascular magnetic resonance imaging is a powerful technology that has evolved into a comprehensive imaging approach to cardiovascular disease. A major focus of our work is on developing and improving clinical applications of cardiovascular MRI. Active clinical projects include a multicenter international registry improving risk prediction in hypertrophic cardiomyopathy using CMR, genetics, and biomarkers when added to standard clinical evaluation, developing a comprehensive MR exam for clinical trials in peripheral arterial disease, including atherosclerotic plaque imaging and calf muscle perfusion and energetics at peak exercise, and assessing quantitative myocardial perfusion in microvascular coronary artery disease.

• Neubauer S, …, Kramer CM, for the HCMR investigators. Distinct Subtypes in Hypertrophic Cardiomyopathy: Baseline Results from the NHLBI HCM Registry. J Am Coll Cardiol, 2019;74:2333-2345. PMID: 31699273
• Kramer CM, et al, The HCMR Investigators. Predictors of atrial fibrillation endpoints in the NHLBI Hypertrophic Cardiomyopathy Registry (HCMR). JACC Clin Electrophys 2021;7:1376-1386. PMID: 34217663
• Sporkin H, … Kramer CM. Chemical exchange saturation transfer MRI identifies abnormal calf muscle-specific energetics in peripheral artery disease. Circulation CV Imaging, 2022; Jul;15(7):e013869. doi: 10.1161/ CIRCIMAGING.121.013869. PMID: 35861977
• Patel AR, … Kramer CM. Stress myocardial perfusion imaging with cardiac magnetic resonance. J Am Coll Cardiol, 2021;78:1655-1668. PMID: 34649703
• Harper AR, … Kramer CM, …. .HCMR Investigators. Common genetic variants and modifiable risk factors underpin susceptibility and expressivity in hypertrophic cardiomyopathy, Nat Gen. 2021;53:135-142. PMID: 33495597